Form 4: H.B. Fuller VP, Corporate Controller Executes Stock Options and Sells Shares
Insider Transaction Report
H.B. Fuller's VP, Corporate Controller, Robert J. Martsching, executed employee stock options and subsequently sold a portion of the acquired common stock for a profit.
Summary
- Robert J. Martsching, VP, Corporate Controller of H.B. Fuller Co. (FUL), engaged in an insider transaction on July 10, 2025.
- Martsching acquired 9,546 shares of common stock by exercising employee stock options at a price of $33.38 per share.
- Concurrently, Martsching disposed of 9,546 shares of common stock at a weighted average sale price of $64.3046 per share, with prices ranging from $64.13 to $64.4150.
- Following these transactions, Martsching beneficially owns 14,979.676 shares of common stock, which includes shares acquired through a dividend reinvestment plan.
- The exercised employee stock option, originally granted at an exercise price of $33.38, is now fully exercised with 0.0000 shares remaining from that specific tranche.
- Martsching retains various other employee stock options with exercise prices ranging from $45.05 to $77.72, and expiration dates extending up to January 27, 2035.
- Remaining derivative holdings also include 3,056.98 phantom units and 1,362.30 restricted stock units (RSUs), which convert to common stock on a 1-for-1 basis and include dividend equivalent features.
Sentiment
Score: 6
Explanation: The document reports a routine insider transaction where an executive exercised stock options and sold shares for a profit. This indicates positive stock performance relative to the option grant price, which is generally favorable, but the transaction itself is a standard part of executive compensation management rather than a strategic corporate announcement.
Positives
- The insider realized a significant profit by exercising options at $33.38 and selling shares at a weighted average of $64.3046, indicating the company's stock price has appreciated considerably since the option grant.
- The transaction was made pursuant to a Rule 10b5-1 plan, suggesting a pre-planned and routine monetization of equity compensation rather than a reactive sale.
Negatives
- An insider selling shares, even if pre-planned, represents a reduction in their direct equity stake in the company.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The transaction is a routine insider sale, which can be interpreted as an executive monetizing vested equity. While it reduces the insider's direct share count, it's a common practice for compensation and tax planning, especially when executed under a Rule 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 01/19/2017 | Date exercisable for an employee stock option tranche (100% vested). |
| 01/26/2018 | Date exercisable for an employee stock option tranche (100% vested). |
| 01/25/2019 | Date exercisable for an employee stock option tranche (100% vested). |
| 01/24/2020 | Date exercisable for an employee stock option tranche (100% vested). |
| 01/24/2021 | Date exercisable for an employee stock option tranche (100% vested). |
| 01/27/2022 | Date exercisable for an employee stock option tranche (100% vested). |
| 01/24/2023 | Date exercisable for an employee stock option tranche (100% vested). |
| 01/24/2024 | Date exercisable for an employee stock option tranche (vests in three annual installments); Vesting start date for a Restricted Stock Unit tranche (vests in three annual installments). |
| 01/26/2025 | Date exercisable for an employee stock option tranche (vests in three annual installments); Vesting start date for a Restricted Stock Unit tranche (vests in three annual installments). |
| 07/10/2025 | Transaction Date for the exercise of employee stock options and subsequent sale of common stock. |
| 07/11/2025 | Date the Form 4 filing was signed. |
| 01/19/2026 | Expiration date for the exercised employee stock option tranche. |
| 01/24/2026 | Expiration date for a Restricted Stock Unit tranche. |
| 01/27/2026 | Date exercisable for an employee stock option tranche (vests in three annual installments); Vesting start date for a Restricted Stock Unit tranche (vests in three annual installments). |
| 01/26/2027 | Expiration date for a Restricted Stock Unit tranche; Expiration date for an employee stock option tranche. |
| 01/27/2028 | Expiration date for a Restricted Stock Unit tranche. |
| 01/25/2028 | Expiration date for an employee stock option tranche. |
| 01/24/2029 | Expiration date for an employee stock option tranche. |
| 01/24/2030 | Expiration date for an employee stock option tranche. |
| 01/27/2031 | Expiration date for an employee stock option tranche. |
| 01/24/2032 | Expiration date for an employee stock option tranche. |
| 01/24/2033 | Expiration date for an employee stock option tranche. |
| 01/26/2034 | Expiration date for an employee stock option tranche. |
| 01/27/2035 | Expiration date for an employee stock option tranche. |
Keywords
H.B. Fuller, FUL, SEC Form 4, Insider Trading, Stock Options, Common Stock, Beneficial Ownership, Equity Compensation, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.